Castle Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.92 M | $77.85 M | -6.38% | 10.49% |
VANGUARD GROUP INC | 02/11/2025 | 1.83 M | $48.84 M | 4.79% | 6.58% |
WASATCH ADVISORS LP | 02/13/2025 | 1.80 M | $47.87 M | -1.64% | 6.45% |
PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 1.44 M | $38.26 M | -6.69% | 5.16% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 999,466 | $26.64 M | 15.57% | 3.59% |
UBS GROUP AG | 02/14/2025 | 812,600 | $21.66 M | 1,401.09% | 2.92% |
PORTOLAN CAPITAL MANAGEMENT, LLC | 02/13/2025 | 776,579 | $20.70 M | -38.15% | 2.79% |
BELLEVUE GROUP AG | 02/14/2025 | 745,982 | $19.88 M | -40.89% | 2.68% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 722,120 | $19.24 M | 100.00% | 2.59% |
STATE STREET CORP | 02/14/2025 | 710,212 | $18.93 M | 4.44% | 2.55% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 685,000 | $18.26 M | 39.92% | 2.46% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 628,196 | $16.75 M | 0.56% | 2.26% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 548,809 | $14.63 M | 290.51% | 1.97% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 547,104 | $14.58 M | 9.60% | 1.97% |
PALISADE CAPITAL MANAGEMENT, LP | 02/14/2025 | 503,442 | $13.42 M | 0.22% | 1.81% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 465,526 | $12.41 M | -14.20% | 1.67% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 432,750 | $11.53 M | 78.23% | 1.55% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 408,650 | $10.89 M | 1.85% | 1.47% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 01/31/2025 | 383,974 | $10.23 M | -5.71% | 1.38% |
ALLIANZ ASSET MANAGEMENT GMBH | 02/03/2025 | 322,374 | $8.59 M | 356.92% | 1.16% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 316,036 | $8.42 M | -9.50% | 1.14% |
PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 304,629 | $8.12 M | 2.89% | 1.09% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 258,866 | $6.90 M | -5.79% | 0.93% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 252,917 | $6.74 M | -61.81% | 0.91% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 249,128 | $6.64 M | 100.00% | 0.89% |
NEXT CENTURY GROWTH INVESTORS LLC | 02/13/2025 | 235,214 | $6.27 M | 0.48% | 0.84% |
INTRINSIC EDGE CAPITAL MANAGEMENT LLC | 02/14/2025 | 232,711 | $6.20 M | 9.40% | 0.84% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 217,544 | $5.80 M | 276.08% | 0.78% |
CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 215,322 | $5.74 M | 2,567.52% | 0.77% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 203,571 | $5.43 M | 27.53% | 0.73% |
SILVERCREST ASSET MANAGEMENT GROUP LLC | 02/14/2025 | 199,950 | $5.33 M | -0.98% | 0.72% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 189,101 | $5.04 M | 2.81% | 0.68% |
ADVISORS CAPITAL MANAGEMENT, LLC | 02/13/2025 | 178,935 | $4.77 M | 6.56% | 0.64% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 177,537 | $4.73 M | -6.84% | 0.64% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 168,713 | $4.50 M | 1.97% | 0.61% |
SHELTON CAPITAL MANAGEMENT | 02/13/2025 | 164,008 | $4.37 M | 0.00% | 0.59% |
ALGERT GLOBAL LLC | 02/14/2025 | 149,491 | $3.98 M | 11.29% | 0.54% |
HARBOR CAPITAL ADVISORS, INC. | 01/10/2025 | 118,500 | $3.16 M | -23.01% | 0.43% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 110,824 | $2.95 M | -73.94% | 0.40% |
JPMORGAN CHASE & CO | 02/12/2025 | 107,936 | $2.88 M | 55.51% | 0.39% |
D. E. SHAW & CO., INC. | 02/14/2025 | 90,563 | $2.41 M | 100.00% | 0.33% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 84,459 | $2.25 M | 10.29% | 0.30% |
BIRCHVIEW CAPITAL, LP | 02/14/2025 | 78,000 | $2.08 M | 34.48% | 0.28% |
FRANKLIN RESOURCES INC | 02/12/2025 | 73,637 | $1.96 M | 6.13% | 0.26% |
HUSSMAN STRATEGIC ADVISORS, INC. | 02/03/2025 | 73,500 | $1.96 M | 100.00% | 0.26% |
ENVESTNET ASSET MANAGEMENT INC | 02/13/2025 | 73,344 | $1.95 M | 8.84% | 0.26% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 70,801 | $1.89 M | 36.61% | 0.25% |
TUDOR INVESTMENT CORP ET AL | 02/14/2025 | 70,076 | $1.87 M | 41.60% | 0.25% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 69,175 | $1.84 M | 28.14% | 0.25% |
ORION PORTFOLIO SOLUTIONS, LLC | 02/12/2025 | 68,316 | $1.82 M | -5.65% | 0.25% |
Castle Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 243 institutional investors and hedge funds held shares of Castle Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 2.92 M
VANGUARD GROUP INC: 1.83 M
WASATCH ADVISORS LP: 1.8 M
PRINCIPAL FINANCIAL GROUP INC: 1.44 M
DIMENSIONAL FUND ADVISORS LP: 999,466
UBS Group AG: 812,600
94.82% of Castle Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 30.31 M shares in the last 24 months. This purchase volume represents approximately $889.92 M in transactions.